XML 68 R56.htm IDEA: XBRL DOCUMENT
v3.22.0.1

License Agreements - InnoCare (Details) - InnoCare - tafasitamab $ in Millions | 1 Months Ended
--- | ---
Sep. 30, 2021 USD ($)
Upfront payment received under license agreement | $ 35.0
Development and Regulatory Milestones | Maximum |
Upfront and immediate milestone payment to be received under license agreement | 45.0
Commercialization Milestones | Maximum |
Upfront and immediate milestone payment to be received under license agreement | $ 37.5

X
- Definition Represents the upfront and immediate milestone payment received under the license agreement. + References No definition available. + Details
Name: | incy_LicenseAgreementUpfrontPaymentAndImmediateMilestonePaymentToBeReceived
Namespace Prefix: | incy_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Represents the upfront payment received under the license agreement. + References No definition available. + Details
Name: | incy_LicenseAgreementUpfrontPaymentReceived
Namespace Prefix: | incy_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=incy_InnocarePharmaLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=incy_TafasitamabMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | incy_AchievementOfMilestoneAxis=incy_DevelopmentAndRegulatoryMilestonesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | incy_AchievementOfMilestoneAxis=incy_CommercializationMilestonesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |